Word

CAIM

Status

Dead

Status Code

606

Status Date

Monday, March 13, 2017

Serial Number

86290520

Mark Type

4000

Filing Date

Friday, May 23, 2014

Published for Opposition

Tuesday, June 9, 2015

Abandoned Date

Monday, March 13, 2017

Trademark Owner History

The Translational Genomics Research Institute - Owner At Publication

Classifications

1 Chemical test kits for genetic testing for laboratory or research use; Assays and reagents for use in genetic research; Genetic identity tests comprised of reagents; Diagnostic preparations for scientific or research use; Nucleic acid isolation and purification kit consisting primarily of reagents for scientific research purposes; Reagents for scientific or medical research use; Testing kits comprised of medical diagnostic reagents and assays that test for the presence of certain genetic properties for scientific and research use

5 Diagnostic agents, preparations and substances for medical purposes; Medical diagnostic reagents for the analysis of genetic material; Preparations for detecting mutation in prion genes for medical purposes; Clinical diagnostic preparations for medical use; Chemical reagents for medical analysis; Chemical diagnostic preparation for use in medical analysis, particularly DNA analysis; Pharmaceutical preparations for diagnosis and for identifying and characterizing genetic abnormalities, tracking the progress of disease and measuring the effectiveness of immunotherapy, and for identifying and characterizing immune dysfunction

41 Consulting services in the field of medical education, namely, providing education and training information relating to the identification, diagnosis and treatment of medical and genetic conditions; Education services, namely, providing live and on-line continuing professional education seminars in the medical, scientific and genetics field; Education services, namely, providing training programs in the field of genetics; Conducting workshops and seminars in genetic testing and disease identification and treatment; Educational services, namely, organization of seminars educational conference attendee working groups and research groups and conventions in the fields of medicine, genetics and scientific research; On-line journals, namely, blogs featuring commentary and information in the fields of DNA identification techniques, practices, and tools; Organization of educational conferences and symposia for the discussion, dissemination and exchange of scientific data and ideas on topics of interest to the scientific community; Providing educational demonstrations regarding biology, molecular biology, genetics, DNA sequencing and bioinformatics; Conducting classes, seminars and workshops in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course materials in connection therewith; Educational services, namely, conducting educational programs in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Educational services, namely, conducting on-line exhibitions and displays and interactive exhibits in biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Organizing exhibitions for education in biology, genetics, genomics, DNA sequencing, bioinformatics and nature study; Providing courses of instruction in the fields of biology, molecular biology, genetics, genomics, DNA sequencing, bioinformatics and nature study and distributing course material in connection therewith; Teaching in the fields of biology, molecular biology, genetics, genomics, DNA sequencing and bioinformatics and nature study

42 Conducting medical and scientific educational research for others on the subjects of biology, molecular biology, genetics, genomics, DNA sequencing, and bioinformatics; Medical and scientific research in the field of genetic testing; Development and laboratory testing in the field of genetics and human disease; Scientific research consulting in the field of genetics, genomics, DNA sequencing, and bioinformatics; Consulting services in the field of pharmaceutical research and development and laboratory testing; Genetic research, development and testing services; Genomic research, development and testing services for scientific research purposes; DNA collection, testing and analysis services for scientific research purposes; Medical and scientific research, development and scientific consulting in the field of oncology; Medical and scientific research in the field of genetics and genetic engineering; Medical and scientific research and consulting in the fields of genomics and generation sequencing; Medical and scientific research in the field of cancer treatment and diagnosis; Data collection for research purposes, namely, the collection, testing and research of patient molecular and/or genomic data; Scientific clinical studies, namely, conducting clinical trials for others; Retrieval and correlation of genomic data for medical and scientific research purposes; Medical and scientific research relating to the design and development of cancer treatment therapies; Conducting clinical and pre-clinical trials for others; Diagnostic services for equipment in the field of molecular science, comparative genome analysis, DNA arrays and screening of nucleic acids; Research and development of identification and treatment methods for hereditary factors leading to disease; Testing and evaluation for scientific purposes, namely, identification of target molecules for cancer treatment; Testing and evaluation for scientific purposes, namely, proteogenomic profiling; DNA-sequencing for scientific research purposes; Targeted pharmaceutical drug development services; Testing and evaluation for scientific purposes, namely, genotyping; Testing and evaluation for scientific purposes, namely, gene screening; Gene isolation and gene expression analysis for scientific research purposes; Testing and evaluation for scientific purposes, namely, gene mapping; Gene analysis and biomarker discovery for scientific research purposes; Collection and preservation of DNA for research purposes

44 Diagnosis and treatment of medical conditions; Genetic testing for diagnostic purposes; Genomic testing for diagnostic purposes; Medical testing for diagnostic or treatment purposes in the field of cancer research; Medical diagnostic testing, monitoring and reporting services; Medical evaluation services; Medical monitoring services; Medical diagnostic, prognostic and theranostic screening and testing; Collection and preservation of DNA for medical purposes; Consulting services in the field of healthcare and cancer diagnoses; Providing a website featuring health and healthcare information related to cancer research, testing and screening; Genetic testing for medical purposes; Providing information in the field of cancer prevention, screening, diagnosis and treatment for medical diagnostic and treatment purposes; Providing genetics assessments in the nature of genetic counseling; Molecular profiling services of patients for use in providing medical and related health care services to patients

Trademark Events

Mar 13, 2017

Abandonment Notice Mailed - No Use Statement Filed

Mar 13, 2017

Abandonment - No Use Statement Filed

Sep 7, 2016

Notice Of Approval Of Extension Request E-Mailed

Sep 6, 2016

Extension 2 Granted

Aug 4, 2016

Extension 2 Filed

Aug 27, 2016

Case Assigned To Intent To Use Paralegal

Aug 4, 2016

Teas Extension Received

Jan 30, 2016

Notice Of Approval Of Extension Request E-Mailed

Jan 28, 2016

Extension 1 Granted

Jan 28, 2016

Extension 1 Filed

Jan 28, 2016

Teas Extension Received

Aug 4, 2015

Noa E-Mailed - Sou Required From Applicant

Jun 9, 2015

Official Gazette Publication Confirmation E-Mailed

Jun 9, 2015

Published For Opposition

May 20, 2015

Notification Of Notice Of Publication E-Mailed

May 1, 2015

Law Office Publication Review Completed

May 1, 2015

Approved For Pub - Principal Register

May 1, 2015

Examiner's Amendment Entered

May 1, 2015

Notification Of Examiners Amendment E-Mailed

May 1, 2015

Examiners Amendment E-Mailed

May 1, 2015

Examiners Amendment -Written

Apr 30, 2015

Previous Allowance Count Withdrawn

Apr 14, 2015

Withdrawn From Pub - Og Review Query

Mar 28, 2015

Law Office Publication Review Completed

Mar 28, 2015

Assigned To Lie

Mar 10, 2015

Approved For Pub - Principal Register

Mar 6, 2015

Assigned To Examiner

Feb 26, 2015

Teas/Email Correspondence Entered

Feb 25, 2015

Correspondence Received In Law Office

Feb 25, 2015

Teas Response To Office Action Received

Feb 24, 2015

Attorney Revoked And/Or Appointed

Feb 24, 2015

Teas Revoke/Appoint Attorney Received

Sep 15, 2014

Notification Of Non-Final Action E-Mailed

Sep 15, 2014

Non-Final Action E-Mailed

Sep 15, 2014

Non-Final Action Written

Sep 8, 2014

Assigned To Examiner

Jun 6, 2014

New Application Office Supplied Data Entered In Tram